GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L'Oreal US settles hair relaxer cancer cases during first trial - Finance news and analysis from Global Banking & Finance Review
Finance

L'Oreal US settles hair relaxer cancer cases during first trial

Published by Global Banking & Finance Review

Posted on November 16, 2026

3 min read

· Last updated: November 16, 2026

Add as preferred source on Google

L'Oreal Settles First Hair Relaxer Cancer Lawsuit During Chicago Trial

Settlement Details and Background of the Lawsuit

By Diana Novak Jones

The Settlement and Parties Involved

CHICAGO, Nov 16 (Reuters) - Four women who said they were diagnosed with cancer as a result of chemical hair straightening products reached a settlement on Monday with L’Oreal's US subsidiary and other companies during a trial in Chicago, according to their attorneys.

The women are among thousands who have sued the companies, alleging that years of using chemical hair straighteners caused them to develop gynecologic cancers. The cases, which were the first to go to trial, settled for a confidential sum, the lawyers said.

L'Oreal's Response and Product Safety

Company Statement on Consumer Health

A spokesperson for L'Oreal said the company's highest priority is the health and wellbeing of its consumers, and it remains confident in the safety of its SoftSheen-Carson brand hair products, which include hair relaxers.

"L’Oréal USA strictly follows all regulations in every market in which it operates, and its products are always subject to a rigorous scientific evaluation of their safety," the spokesperson said.

Legal Proceedings and Plaintiffs

Attorneys and Plaintiffs' Perspective

In a statement, Danielle Ward Mason, an attorney for the women, MaryAnne Lindsey, Surenthia Jenkins, Miranda Lofton and Sandra Simpson, said she hoped the settlement would give the women a sense of justice.

The women sued L’Oreal's US subsidiary and several other makers of the products in Cook County, Illinois, in 2023 and 2024. The trial began on November 9 with jury selection.

Scope of Litigation

While some cases have been filed in state court, more than 12,700 cases over the claims are centralized before a judge in federal court in Chicago, court records show.

Background on Hair Relaxer Products

Marketing and Target Demographics

The products, which have been marketed under the names Dark and Lovely, Optimum and other brands, promise to permanently straighten textured hair and have been widely marketed to Black women.

Scientific Studies and Health Concerns

NIH Study Findings

The first lawsuits hit the docket ​after the 2022 release ​of a study done ⁠by the National Institutes of Health that found women who used the products several times a year were more than twice as likely to develop uterine ​cancer.

L'Oreal's Position on Study Results

L'Oreal has said the study did not establish a causal link ​between the ⁠use of the products and any conditions alleged by the plaintiffs.

State-Level Legal Actions

At least two states, Arizona and Minnesota, sued L’Oreal over the products this year, alleging that the company had misled women about their safety.

(Reporting by Diana Novak Jones, Editing by Alexia Garamfalvi and Aurora Ellis)

Key Takeaways

  • Four women settled cancer claims during the first trial in Chicago on November 16, 2026.
  • More than 12,700 federal MDL cases remain pending; no global settlement has been reached.
  • L’Oréal faces state-level lawsuits (e.g., Arizona, Minnesota) accusing it of misleading consumers about cancer risks associated with hair relaxers.
  • Scientific studies, including a 2022 NIH‑funded study and a cohort study of Black women, report elevated uterine cancer risks among frequent users of chemical straighteners.

Frequently Asked Questions

What was the basis of the lawsuit against L'Oreal regarding hair relaxers?
Women alleged that years of using chemical hair straightening products from L'Oreal caused them to develop gynecologic cancers.
How many cases are pending over claims related to hair relaxers?
More than 12,700 similar cases are centralized before a federal judge in Chicago.
What brands were named in the lawsuits?
Products marketed under names such as SoftSheen-Carson, Dark and Lovely, and Optimum were included.
What did the recent NIH study say about hair straighteners and cancer risk?
The study found women using these products several times a year were more than twice as likely to develop uterine cancer.
Was the settlement amount between L'Oreal and the plaintiffs disclosed?
No, the settlement was for a confidential sum.

Tags

Related Articles

More from Finance

Explore more articles in the Finance category